Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide

医学 乳腺癌 肿瘤科 癌症 肽 癌症研究 内科学 生物化学 生物
作者
Javad Biabani Ardakani,Seyed Mohammad Abedi,Alireza Mardanshahi,Leyla Shojaee,Ehsan Zaboli,Alireza Khorrami Moghadam,Anahita Nosrati,Hamideh Sabahnoo,Elham Sadat Banimostafavi,Seyed Jalal Hosseinimehr
出处
期刊:Clinical Breast Cancer [Elsevier BV]
卷期号:23 (2): 219-230 被引量:14
标识
DOI:10.1016/j.clbc.2022.12.002
摘要

The accurate determination of human epidermal growth factor receptor 2 (HER2) status can predict response to treatment with HER2-targeted therapy for HER2-positive breast cancer patients. [99mTc]Tc-HYNIC-(Ser)3-LTVPWY ([99mTc]Tc-HYNIC-LY) is a small synthetic peptide molecule targeting of the HER2 receptor. This clinical study evaluated the pharmacokinetic, dosimetry, and efficacy of [99mTc]Tc-HYNIC-LY for determining the HER2 status in primary breast cancer patients.In total, 24 women with suspected primary breast cancer received an intravenous injection of approximately 20 µg (∼740 MBq) of [99mTc]Tc-HYNIC-LY. In the first 3 patients, blood levels of radioactivity were analyzed for pharmacokinetic evaluation and planar gamma camera imaging was conducted at 30 min and 1, 2, 4, and 24 hour after injection for dosimetry assessment. In the last 21 patients, planar imaging was performed at the baseline, as well as 1, 2, 3, and 4 hour, followed by single-photon emission computed tomography (SPECT) imaging after 4 hour to evaluate the tumor-targeting potential in primary lesions.Injection of [99mTc]Tc-HYNIC-LY was safe and well tolerated. Fast blood clearance provided high-contrast HER2 imaging within 1 to 4 hour. The highest absorbed radiation dose was found for kidneys (6.78E-03 ± 2.62E-04 mSv/MBq), followed by the heart (3.73E-03 ± 1.98E-04 mSv/MBq). The [99mTc]Tc-HYNIC-LY peptide was able to detect HER2 status in primary tumors at an acceptable level.The findings of this study indicated that [99mTc]Tc-HYNIC-LY SPECT is safe and feasible for the identification of HER2-positive lesions in primary breast cancer patients, and may provide an accurate and non-invasive modality for guiding HER2 targeted therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
HankChou发布了新的文献求助10
1秒前
小张关注了科研通微信公众号
2秒前
AUK发布了新的文献求助10
2秒前
烂漫的绫发布了新的文献求助10
2秒前
4秒前
4秒前
4秒前
12345完成签到,获得积分10
4秒前
6秒前
wjz完成签到,获得积分10
7秒前
8秒前
8秒前
Jing发布了新的文献求助10
8秒前
8秒前
whs发布了新的文献求助10
8秒前
rrr完成签到,获得积分10
8秒前
华仔的应助被豆奶粉或采纳,获得10
8秒前
小蘑菇的应助被一一采纳,获得10
9秒前
xiuuu发布了新的文献求助10
10秒前
Ari发布了新的文献求助10
10秒前
orixero的应助被OuyangShuo采纳,获得10
10秒前
10秒前
11秒前
酷波er的应助被zx采纳,获得10
12秒前
搜集达人的应助被AUK采纳,获得10
12秒前
13秒前
往不随发布了新的文献求助10
13秒前
WZJ发布了新的文献求助10
13秒前
13秒前
bronny完成签到,获得积分20
16秒前
JeanetteJin发布了新的文献求助10
16秒前
CipherSage的应助被勤恳的铲丝采纳,获得10
16秒前
在水一方的应助被succo采纳,获得10
16秒前
xxxg郭完成签到 ,获得积分10
17秒前
17秒前
琪琪发布了新的文献求助10
17秒前
18秒前
18秒前
赘婿的应助被ayzzdbr采纳,获得10
18秒前
cdercder的应助被而非哈随哈桑采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177654
求助须知:如何正确求助?哪些是违规求助? 9568503
关于积分的说明 21799551
捐赠科研通 7772253
什么是DOI,文献DOI怎么找? 3432428
关于科研通互助平台的介绍 2556594
邀请新用户注册赠送积分活动 2478011